Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiya Horimoto

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
Case Reports in Oncology|November 30, 2020
Difficulty Diagnosing a Brain Tumor during Clinical Maintenance of a Complete Response to anti-HER2 Treatments for Metastatic Breast Cancer: A Case ReportRyoko Semba, Yoshiya Horimoto, Atsushi Arakawa, et al.
Surgical Case Reports|October 22, 2025
A Case of Occult Breast Cancer Diagnosed during Immune Checkpoint Inhibitor Treatment for Recurrent Metastatic Lung CancerMio Makino, Hiroki Kusama, Masaru Hagiwara, et al.
Virchows Archiv : an International Journal of Pathology|February 24, 2025
FOXA1 expression and its association with mucin expression and KRAS mutation in ovarian mucinous tumors: implications for tumor progression and differentiationMen Yuan, Harumi Saeki, Takuo Hayashi, et al.
American Journal of Cancer Research|September 9, 2020
Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cellsSei Sai, Eun Ho Kim, Guillaume Vares, et al.
Case Reports in Oncology|August 25, 2018
Overcoming the Adverse Effects of Everolimus to Achieve Maximum Efficacy in the Treatment of Inoperable Breast Cancer: A Review of 11 Cases at Our HospitalYuko Yoshida-Ichikawa, Masahiko Tanabe, Emi Tokuda, et al.
Medical Oncology (Northwood, London, England)|March 10, 2018
Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancerMisato Okazaki, Yoshiya Horimoto, Masahiko Tanabe, et al.
World Journal of Oncology|January 5, 2026
Organ-Specific Clinicopathological Features That Are Associated With Post-Relapse Survival of Metastatic Breast Cancer in Japanese Women: A Multicenter Cohort StudyYoichi Koyama, Yoshiya Horimoto, Akimitsu Yamada, et al.
Surgical Case Reports|April 24, 2024
A case of phyllodes tumor with rapid growth during pregnancy and lactation period: a case reportShiori Tohyama, Yoshiya Horimoto, Yumiko Ushiyama, et al.
Japanese Journal of Clinical Oncology|March 24, 2024
Emerging measurements for tumor-infiltrating lymphocytes in breast cancerRongrong Wu, Yoshiya Horimoto, Masanori Oshi, et al.
Surgical Case Reports|November 1, 2023
IgG4-related mastitis characterized by skin thickening of the breast: a case reportMoe Itakura, Yoshiya Horimoto, Yumiko Ishizuka, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Case Reports in Oncology|November 30, 2020
Difficulty Diagnosing a Brain Tumor during Clinical Maintenance of a Complete Response to anti-HER2 Treatments for Metastatic Breast Cancer: A Case ReportRyoko Semba, Yoshiya Horimoto, Atsushi Arakawa, et al.
Surgical Case Reports|October 22, 2025
A Case of Occult Breast Cancer Diagnosed during Immune Checkpoint Inhibitor Treatment for Recurrent Metastatic Lung CancerMio Makino, Hiroki Kusama, Masaru Hagiwara, et al.
Virchows Archiv : an International Journal of Pathology|February 24, 2025
FOXA1 expression and its association with mucin expression and KRAS mutation in ovarian mucinous tumors: implications for tumor progression and differentiationMen Yuan, Harumi Saeki, Takuo Hayashi, et al.
American Journal of Cancer Research|September 9, 2020
Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cellsSei Sai, Eun Ho Kim, Guillaume Vares, et al.
Case Reports in Oncology|August 25, 2018
Overcoming the Adverse Effects of Everolimus to Achieve Maximum Efficacy in the Treatment of Inoperable Breast Cancer: A Review of 11 Cases at Our HospitalYuko Yoshida-Ichikawa, Masahiko Tanabe, Emi Tokuda, et al.
Medical Oncology (Northwood, London, England)|March 10, 2018
Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancerMisato Okazaki, Yoshiya Horimoto, Masahiko Tanabe, et al.
World Journal of Oncology|January 5, 2026
Organ-Specific Clinicopathological Features That Are Associated With Post-Relapse Survival of Metastatic Breast Cancer in Japanese Women: A Multicenter Cohort StudyYoichi Koyama, Yoshiya Horimoto, Akimitsu Yamada, et al.
Surgical Case Reports|April 24, 2024
A case of phyllodes tumor with rapid growth during pregnancy and lactation period: a case reportShiori Tohyama, Yoshiya Horimoto, Yumiko Ushiyama, et al.
Japanese Journal of Clinical Oncology|March 24, 2024
Emerging measurements for tumor-infiltrating lymphocytes in breast cancerRongrong Wu, Yoshiya Horimoto, Masanori Oshi, et al.
Surgical Case Reports|November 1, 2023
IgG4-related mastitis characterized by skin thickening of the breast: a case reportMoe Itakura, Yoshiya Horimoto, Yumiko Ishizuka, et al.
Pageof 13